LA MAGDALENIENNE DE BRUNIQUEL.GUERRET M.1952; BULL.SOC.SCI.NAT.,TARN-ET-GARONNE; FRA; 1952, VOL. 1, P. 26 A 27Miscellaneous

LES SQUELETTES MAGDALENIENS DU MUSEE DE MONTAUBAN.GUERRET M.1954; RECUEIL ACAD. SCI. BELLES-LETTRES ARTS, TARN-ET-GARONNE; FRA; 1954, VOL. 8, P. 48 A 66Miscellaneous

DETERMINATION OF PINDOLOL IN BIOLOGICAL FLUIDS BY AN ELECTRON-CAPTURE GAS-LIQUID CHROMATOGRAPHIC METHOD ON A WALL-COATED OPEN TUBULAR COLUMNGUERRET M.1980; J. CHROMATOGR.; ISSN 0021-9673; NLD; DA. 1980; VOL. 221; NO 2; PP. 387-392; BIBL. 2 REF.Article

DETERMINATION OF PINDOLOL IN BIOLOGICAL FLUIDS BY ELECTRON-CAPTURE GLCGUERRET M; LAVENE D; KIECHEL JR et al.1980; J. PHARM. SCI.; ISSN 0022-3549; USA; DA. 1980; VOL. 69; NO 10; PP. 1191-1193; BIBL. 12 REF.Article

DETERMINATION OF 3-HYDROXY-GUANFACINE IN BIOLOGICAL FLUIDS BY ELECTRON-CAPTURE GAS-LIQUID CHROMATOGRAPHYGUERRET M; JULIEN LAROSE C; KIECHEL JR et al.1982; JOURNAL OF CHROMATOGRAPHY; ISSN 0021-9673; NLD; DA. 1982-12; VOL. 233; PP. 181-192; BIBL. 5 REF.Article

THE EFFECT OF FOOD AND CLOPAMIDE ON THE ABSORPTION OF PINDOLOL IN MANKIGER JL; LAVENE D; GUILLAUME MF et al.1976; INTERNATION. J. CLIN. PHARMACOL. BIOPHARM.; GERM.; DA. 1976; VOL. 13; NO 3; PP. 228-232; BIBL. 5 REF.Article

DETERMINATION OF GUANFACINE IN BIOLOGICAL FLUIDS BY ELECTRON-CAPTURE GLCGUERRET M; LAVENE D; LONGCHAMPT J et al.1979; J. PHARM. SCI.; USA; DA. 1979; VOL. 68; NO 2; PP. 219-221; BIBL. 5 REF.Article

DETERMINATION SIMULTANEE PAR CHROMATOGRAPHIE EN PHASE GAZEUSE DU BUTALBITAL, DE LA CAFEINE, DE L'AMIDOPYRINE ET DE DEUX METABOLITES DE CETTE DERNIERE DANS LE PLASMA ET L'URINELAVENE D; GUERRET M; HUMBERT H et al.1974; ANN. PHARM. FR.; FR.; DA. 1974; VOL. 32; NO 9-10; PP. 505-512; ABS. ANGL.; BIBL. 16REF.Article

Hypotensive effect and pharmacokinetics of nicardipine in patients with severe renal failureCLAIR, F; BELLET, M; GUERRET, M et al.Current therapeutic research. 1985, Vol 38, Num 1, pp 74-82, issn 0011-393XArticle

Effect of meal timing not critical for the pharmacokinetics of tegaserod (HTF 919)ZHOU, H; KHALILIEH, S; LAU, H et al.Journal of clinical pharmacology. 1999, Vol 39, Num 9, pp 911-919, issn 0091-2700Article

Simultaneous study of the pharmacokinetics of intravenous and oral nicardipine using a stable isotopeGUERRET, M; CHEYMOL, G; HUBERT, M et al.European journal of clinical pharmacology. 1989, Vol 37, Num 4, pp 381-385, issn 0031-6970Article

Longitudinal assessment of a P-glycoprotein-mediated drug interaction of valspodar on digoxinKOVARIK, J. M; RIGAUDY, L; GUERRET, M et al.Clinical pharmacology and therapeutics. 1999, Vol 66, Num 4, pp 391-400, issn 0009-9236Article

Diclofenac Combined with cyclosporine in treatment refractory rheumatoid arthritis : Longitudinal safety assessment and evidence of a pharmacokinetic/dynamic interactionKOVARIK, J. M; KURKI, P; MUELLER, E et al.Journal of rheumatology. 1996, Vol 23, Num 12, pp 2033-2038, issn 0315-162XArticle

A mathematical model for dynamics of cardiovascular drug action : application to intravenous dihydropyridines in healthy volunteersFRANCHETEAU, P; STEIMER, J.-L; MERDJAN, H et al.Journal of pharmacokinetics and biopharmaceutics. 1993, Vol 21, Num 5, pp 489-514, issn 0090-466XArticle

Routine determination of morphine, morphine 3-β-D-glucuronide and morphine 6-β-D-glucuronide in human serum by liquid chromatography coupled to electrospray mass spectrometryBLANCHET, M; BRU, G; GUERRET, M et al.Journal of chromatography. 1999, Vol 854, Num 1-2, pp 93-108, issn 0021-9673Conference Paper

Evaluation of effects of terbinafine on single oral dose pharmacokinetics and anticoagulant actions of warfarin in healthy volunteersGUERRET, M; FRANCHETEAU, P; HUBERT, M et al.Pharmacotherapy. 1997, Vol 17, Num 4, pp 767-773, issn 0277-0008Article

The preparation and acute antihypertensive effects of a nanocapsular form of darodipine, a dihydropyridine calcium entry blockerHUBERT, B; ATKINSON, J; GUERRET, M et al.Pharmaceutical research. 1991, Vol 8, Num 6, pp 734-738, issn 0724-8741Article

Influence of digestive secretions and food on intestinal absorption of nicardipineDELCHIER, J. C; GUERRET, M; VIDON, N et al.European journal of clinical pharmacology. 1988, Vol 34, Num 2, pp 165-171, issn 0031-6970Article

Role of isoflurane on hemodynamic properties and disposition of nicardipineCHELLY, J. E; HYSING, E. S; ABERNETHY, D. R et al.The Journal of pharmacology and experimental therapeutics. 1987, Vol 241, Num 3, pp 899-906, issn 0022-3565Article

Pharmacokinetic aspects of guanfacine withdrawal syndrome in a hypertensive patient with chronic renal failureKIECHEL, J. R; LAVENE, D; GUERRET, M et al.European journal of clinical pharmacology. 1983, Vol 25, Num 4, pp 463-466, issn 0031-6970Article

Cyclosporine and nonsteroidal antiinflammatory drugs : Exploring potential drug interactions and their implications for the treatment of rheumatoid arthritisKOVARIK, J. M; MUELLER, E. A; GERBEAU, C et al.Journal of clinical pharmacology. 1997, Vol 37, Num 4, pp 336-343, issn 0091-2700Article

Effects of terbinafine on the pharmacokinetics of digoxin in healthy volunteersTARRAL, A; FRANCHETEAU, P; GUERRET, M et al.Pharmacotherapy. 1997, Vol 17, Num 4, pp 791-795, issn 0277-0008Article

Kinetics and hemodynamic effects of intravenous nicardipine modified by previous propranolol oral treatmentROCHA, P; GUERRET, M; DAVID, D et al.Cardiovascular drugs and therapy. 1990, Vol 4, Num 6, pp 1525-1532, issn 0920-3206, 8 p.Article

Estimation of the absolute oral bioavailability of pindolol by two analytical methodsGUERRET, M; CHEYMOL, G; AUBRY, J. P et al.European journal of clinical pharmacology. 1983, Vol 25, Num 3, pp 357-359, issn 0031-6970Article

ETUDE PHARMACOCINETIQUE DE LA GUANFACINE CHEZ L'INSUFFISANT RENAL ET L'HEMODIALYSEKIECHEL JR; LAVENE D; GUERRET M et al.1980; NEPHROL.; CHE; DA. 1980; VOL. 1; NO 2; PP. 73-81; ABS. ENG; BIBL. 6 REF.Article